Literature DB >> 29497978

Repeated Clostridium difficile infection after living donor liver transplantation.

Kyohei Abe1, Hiroaki Shiba2, Kenei Furukawa2, Taro Sakamoto2, Yuichi Ishida2, Katsuhiko Yanaga2.   

Abstract

Liver transplant recipients are considered to be at high risk for Clostridium difficile infection, with an incidence of 2.7-8.0%, which is three times higher than that among other patients. A case of a patient who suffered from pseudomembranous colitis five times after living donor liver transplantation is reported. A 60-year-old woman underwent splenectomy and living donor liver transplantation using the left lobe of her spouse for primary biliary cirrhosis. The patient made a satisfactory recovery, except for splenic vein thrombosis. She was discharged on postoperative day 36; however, she developed pseudomembranous colitis due to Clostridium difficile infection five times within 6 months after transplant and was treated with oral vancomycin each time. At the fifth recurrence of pseudomembranous colitis, the patient received vancomycin taper treatment, dietary counseling, and repeat instructions regarding hand hygiene and house cleaning. The patient recovered and is currently well without recurrence of Clostridium difficile infection 36 months after living donor liver transplantation.

Entities:  

Keywords:  Clostridium difficile; Liver transplant recipients; Vancomycin taper treatment

Mesh:

Substances:

Year:  2018        PMID: 29497978     DOI: 10.1007/s12328-018-0840-x

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  13 in total

1.  Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series.

Authors:  Guy Neff; Victoria Zacharias; Tiffany E Kaiser; Amy Gaddis; Nyingi Kemmer
Journal:  Liver Transpl       Date:  2010-08       Impact factor: 5.799

2.  Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco; D Gordon; W C Fortson
Journal:  Am J Gastroenterol       Date:  1985-11       Impact factor: 10.864

3.  Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Shahryar Ahmad; Nilay Kumar; Gagan Kumar; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

4.  Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes.

Authors:  C Mittal; S Hassan; S Arshad; S Jeepalyam; S Bruni; M Miceli; G Jacobsen; M Abouljoud; I Bajjoka; M Ramesh; G Alangaden
Journal:  Am J Transplant       Date:  2014-06-05       Impact factor: 8.086

5.  Clostridium difficile colitis in solid organ transplantation--a single-center experience.

Authors:  I Stelzmueller; H Goegele; M Biebl; S Wiesmayr; N Berger; W Tabarelli; E Ruttmann; J Albright; R Margreiter; M Fille; H Bonatti
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

6.  Liver graft failure and hyperbilirubinemia in liver transplantation recipients after Clostridium difficile infection.

Authors:  C Rochon; A Kardashian; B Mahadevappa; G Gunasekaran; J Sharma; P Sheiner
Journal:  Transplant Proc       Date:  2011-12       Impact factor: 1.066

7.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.

Authors:  Lynne V McFarland; Gary W Elmer; Christina M Surawicz
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

8.  Early and late onset Clostridium difficile-associated colitis following liver transplantation.

Authors:  Jeffrey B Albright; Hugo Bonatti; Julio Mendez; David Kramer; John Stauffer; Ronald Hinder; Jaime A Michel; Rolland C Dickson; Chris Hughes; Justin Nguyen; Heidi Chua; Walter Hellinger
Journal:  Transpl Int       Date:  2007-10       Impact factor: 3.782

9.  Clostridium difficile-associated diarrhea after living donor liver transplantation.

Authors:  Masao Hashimoto; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

10.  Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants.

Authors:  Jennifer L Hsu; James J Enser; Trevor McKown; Glen E Leverson; John D Pirsch; Timothy M Hess; Nasia Safdar
Journal:  Clin Transplant       Date:  2014-01-30       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.